News Novavax, Inc.

Equities

NVAX

US6700024010

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-13 pm EDT			5-day change	1st Jan Change
10.24 ^USD	-0.63%		+2.56%	+52.31%

Mar. 10	Novavax, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-10-2026 03:40 PM
Mar. 03	Novavax, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 02:30 PM

All News

Mar. 10	Novavax, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-10-2026 03:40 PM
Mar. 03	Novavax, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 02:30 PM
Feb. 26	Health Care Down Amid Mixed Earnings -- Health Care Roundup	DJ
Feb. 26	Novavax raises revenue forecast on boost from vaccine deals, shares soar	RE
Feb. 26	Novavax to Participate in Upcoming Investor Conferences	PR
Feb. 26	Keros Therapeutics, Inc. Announces Board Changes, Effective March 9, 2026	CI
Feb. 26	Novavax outlook 2026 adjusted total revenue $230 mln - $270 mln	RE
Feb. 26	Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals	RE
Feb. 26	Novavax, Inc., Q4 2025 Earnings Call, Feb 26, 2026
Feb. 26	Top Midday Gainers	MT
Feb. 26	Novavax, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
Feb. 26	Novavax Shares Jump After Swinging to Profit in Q4	MT
Feb. 26	Novavax raises revenue forecast on boost from vaccine deals, shares soar	RE
Feb. 26	Earnings Flash (NVAX) Novavax Posts Q4 Total Revenue $147.1M, vs. FactSet Est of $89.8M	MT
Feb. 26	Earnings Flash (NVAX) Novavax Posts Q4 EPS $0.11, vs. FactSet Est of $0.48 Loss	MT
Feb. 26	Novavax: Q4 Earnings Snapshot	AQ
Feb. 26	Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights	PR
Feb. 19	Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026	PR
Jan. 22	Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality	RE
Jan. 20	Novavax Strikes License Deal With Pfizer for Use of Matrix-M Adjuvant	DJ
Jan. 20	Novavax, Inc. Enters into A License and Option Agreement with Pfizer Inc	CI
Jan. 20	Novavax Enters Non-Exclusive Licensing Deal With Pfizer	MT
Jan. 20	Novavax Inc enters license agreement with Pfizer - SEC filing	RE
Jan. 20	Novavax signs licensing agreement with Pfizer for vaccine development	RE
Jan. 20	Novavax Announces Entering into a License Agreement with Pfizer	PR